Faron Pharma said its cash savings efforts have extended its runway until the third quarter of this year while financier IPF has granted a waiver until the end of June to help find further funding for cancer treatment bexmarilimab.
The waiver extension comes with conditions attached but Faron's incoming chief executive, Juho Jalkanen, said: "I want to truly thank all our vendors, employees, IPF and everybody involved.
Endeavour’s announcement that the Sabodala-Massawa BIOX expansion project achieved a first gold pour just two years after construction launch is an important strategic milestone, says broker Stifel.
According to the broker, the mine accounts for roughly a third of NAV and refractory ore represents 41% of reserves, so delivery of the BIOX plant is an important strategic milestone.
Kodal Minerals has tweaked the terms agreed to terminate the right of first refusal (ROFR) granted to Suay Chin over 80% of the spodumene product produced at the Bougouni lithium project in Southern Mali.
Suay Chin's agreed termination fee of US$14 million payable by Kodal Mining UK, the Bougouni company 51% owned by Hainan Mining, will now be paid in three instalments, rather than two.
Light Science Technologies Holdings PLC (AIM:LST) said it was "pleased to see the continuation of the strong momentum building in the group" as it updated on current trading.
It has three distinct businesses: controlled environment agriculture (CEA), contract electronics manufacturing (CEM), and passive fire protection (PFP).
Poolbeg Pharma PLC (AIM:POLB) has inked an exclusive 12-month option agreement to acquire a phase III-ready treatment from Silk Road Therapeutics Inc that is being developed for oral ulcers associated with Behçet's Disease.
Interestingly, the topical muco-adherent formulation of Pentoxifylline (PTX) has acquired orphan drug and fast-track status from the US Food & Drug Administration.
Greatland Gold has indicated it might try to buy back full ownership of the Havieron gold project in the Pilbara, Western Australia if the opportunity arose.
In February, Newmont, the majority partner at Havieron via a 70/30 joint venture with Greatland, deemed the project non-core.